top of page
Case Studies


Why Global MedTech Expansion Fails Quietly and How to Stop the Leak
I’ve watched strong technologies fail overseas for one reason: companies treat expansion like a checklist instead of a system. Not bad science. Not lack of demand. Execution. The failure isn’t loud. No recalls or headlines. Just two years of burn, optimistic updates, then a quiet retreat. The P&L shows it. The post-mortem rarely explains it. I’ve also seen international become the most profitable part of the business. Same industry. Similar resources. Different approach. Most
3 days ago4 min read
bottom of page

%20(1).png)